Autres langues LivaNova PLC

Actions

LIVN

GB00BYMT0J19

Temps réel estimé Cboe BZX Autres places de cotation 17:56:45 30/04/2024			Varia. 5j.	Varia. 1 janv.
56,1 ^USD	-0,12 %		+2,15 %	+8,63 %

20/03	Mise à jour sectorielle : Les actions du secteur de la santé ralentissent en fin d'après-midi	MT
20/03	Mise à jour sectorielle : Les actions du secteur de la santé en baisse mercredi après-midi	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer	15:12
LivaNova PLC Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer	15:00
LivaNova : 2023 UK Annual Report	26/04
LivaNova : 2024 Proxy Statement and Notice of Annual General Meeting	26/04
LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident	25/04
LivaNova to Announce First-Quarter 2024 Results	21/03
Sector Update: Health Care Stocks Ease Late Afternoon	20/03
Sector Update: Health Care Stocks Down Wednesday Afternoon	20/03
LivaNova Says Sleep Apnea Study Likely to Meet Primary Efficacy Endpoint; Shares Jump	20/03
LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea	20/03
LivaNova PLC Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea	20/03
LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029	06/03
LivaNova Proposes $300 Million Private Placement of Notes	04/03
LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes	04/03
LivaNova to Present at the Barclays Global Healthcare Conference	04/03
LivaNova's Q4 Adjusted Earnings, Revenue Increase; Sets 2024 Guidance	21/02
LivaNova: Q4 Earnings Snapshot	21/02
Earnings Flash (LIVN) LIVANOVA Reports Q4 Revenue $310.1M, vs. Street Est of $287.7M	21/02
Earnings Flash (LIVN) LIVANOVA Reports Q4 EPS $0.87, vs. Street Est of $0.77	21/02
LivaNova Reports Fourth-Quarter and Full-Year 2023 Results	21/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues LivaNova PLC

Actions

LIVN

GB00BYMT0J19

Autres langues

Filtres